Zinger Key Points
- D-Wave shares jump over 40% after posting record revenue and gross profit, driven by its first major quantum system sale.
- "The first quarter of 2025 was arguably the most significant in D-Wave's history," the company says.
- Don’t miss this list of 3 high-yield stocks—including one delivering over 10%—built for income in today’s chaotic market.
D-Wave Quantum Inc. QBTS shares are trading higher Thursday after the company posted record first-quarter 2025 financial results and highlighted major technical milestones in commercial quantum computing.
What To Know: The quantum company reported revenue of $15 million for the quarter ended March 31, a more than sixfold increase on a year-over-year basis. The revenue boost was largely driven by the first recognized sale of its Advantage quantum computing system to a major research institution, along with increased adoption of its hybrid quantum solutions by clients.
D-Wave Quantum reported a first-quarter loss of 2 cents per share, beating estimates for a loss of 7 cents per share, according to Benzinga Pro. Gross profit came in at $13.9 million, up from $1.7 million a year earlier, and gross margin climbed to over 92% in the quarter.
D-Wave also reported a record cash balance of $304.3 million, citing proceeds from its third At-The-Market program.
“The first quarter of 2025 was arguably the most significant in D-Wave’s history, especially in terms of our unique ability to deliver quantum value today to our customers and the scientific community,” said Alan Baratz, CEO of D-Wave.
In addition to strong financial performance, the company highlighted a milestone achievement in quantum computing. D-Wave announced that it demonstrated quantum supremacy on a real-world problem, simulating magnetic materials faster than a classical supercomputer could achieve within a feasible timeframe.
D-Wave also cited new commercial deployments, including Ford Otosan's use of its technology to drastically reduce vehicle scheduling time and a quantum-AI collaboration with Japan Tobacco's pharmaceutical arm for drug discovery. The company noted that its Advantage2 system, built for defense applications, is undergoing final testing in Alabama.
Despite a decline in bookings year-over-year, investors focused on the record revenue, cash position and quantum milestones, which collectively signaled strong momentum in D-Wave's path toward commercial viability.
QBTS Price Action: D-wave quantum shares were up 41.3% at $9.73 at the time of publication Thursday, according to Benzinga Pro.
Read Next:
Image via Shutterstock.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.